ACRV vs MSFT: Which Stock is Better?
Side-by-side comparison of Acrivon Therapeutics Inc and Microsoft Corp in 2026
ACRV
Acrivon Therapeutics Inc
$1.96
MSFT
Microsoft Corp
$454.50
Key Metrics Comparison
| Metric | ACRV | MSFT | Winner |
|---|---|---|---|
| Market Cap | $61.85M | $3.38T | MSFT |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | 0.0% | 14.9% | MSFT |
| Gross Margin | 0.0% | 68.8% | MSFT |
Analyze ACRV
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACRV or MSFT a better investment?
Comparing ACRV and MSFT: Acrivon Therapeutics Inc has a market cap of $61.85M while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACRV and MSFT?
ACRV (Acrivon Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACRV or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACRV or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.0% for ACRV.
Which company is more profitable: ACRV or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 0.0% for ACRV.
Which is the larger company: ACRV or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $61.85M for ACRV.
Should I buy ACRV or MSFT in 2026?
Both ACRV and MSFT have investment merit. ACRV trades at $1.96 while MSFT trades at $454.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACRV and MSFT stock?
Key differences: Market Cap ($61.85M vs $3.38T), P/E Ratio (N/A vs 36.3x), Revenue Growth (0.0% vs 14.9%), Gross Margin (0.0% vs 68.8%).